News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,010 Results
Type
Article (49685)
Company Profile (278)
Press Release (684047)
Section
Business (212265)
Career Advice (2098)
Deals (36531)
Drug Delivery (103)
Drug Development (83604)
Employer Resources (173)
FDA (16959)
Job Trends (15706)
News (359195)
Policy (34663)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2774)
Accelerated approval (4)
Adcomms (23)
Allergies (83)
Alliances (51554)
ALS (87)
Alzheimer's disease (1417)
Antibody-drug conjugate (ADC) (114)
Approvals (16958)
Artificial intelligence (256)
Autoimmune disease (17)
Automation (14)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (191)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (262)
Cancer (2068)
Cardiovascular disease (172)
Career advice (1758)
Career pathing (30)
CAR-T (143)
Cell therapy (403)
Cervical cancer (21)
Clinical research (67663)
Collaboration (794)
Compensation (466)
Complete response letters (21)
COVID-19 (2710)
CRISPR (36)
C-suite (221)
Cystic fibrosis (99)
Data (2001)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (256)
Diagnostics (6550)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (114)
Drug pricing (102)
Drug shortages (28)
Duchenne muscular dystrophy (87)
Earnings (88360)
Editorial (34)
Employer branding (21)
Employer resources (147)
Events (116713)
Executive appointments (666)
FDA (18121)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (711)
Gene editing (100)
Generative AI (24)
Gene therapy (285)
GLP-1 (737)
Government (4652)
Grass and pollen (4)
Guidances (49)
Healthcare (19896)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (107)
Indications (27)
Infectious disease (2848)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (87)
Interviews (319)
IPO (16854)
IRA (41)
Job creations (4043)
Job search strategy (1501)
Kidney cancer (9)
Labor market (34)
Layoffs (472)
Leadership (16)
Legal (8456)
Liver cancer (73)
Lung cancer (302)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (274)
MASH (64)
Medical device (14331)
Medtech (14336)
Mergers & acquisitions (20163)
Metabolic disorders (668)
Multiple sclerosis (74)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (28)
Neuroscience (1926)
NextGen: Class of 2025 (6911)
Non-profit (4736)
Northern California (2464)
Now hiring (37)
Obesity (363)
Opinion (215)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (77)
Parkinson's disease (142)
Partnered (20)
Patents (207)
Patient recruitment (98)
Peanut (48)
People (59960)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21047)
Phase II (29728)
Phase III (22225)
Pipeline (1064)
Podcasts (58)
Policy (116)
Postmarket research (2741)
Preclinical (8943)
Press Release (67)
Prostate cancer (97)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (370)
Real estate (6298)
Recruiting (65)
Regulatory (23576)
Reports (46)
Research institute (2480)
Resumes & cover letters (359)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (71)
Series A (122)
Series B (80)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2137)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3826)
State (2)
Stomach cancer (14)
Supply chain (63)
Tariffs (11)
The Weekly (30)
United States (21795)
Vaccines (697)
Venture capitalists (38)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (15)
Date
Today (110)
Last 7 days (738)
Last 30 days (2749)
Last 365 days (34315)
2025 (8446)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (50)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (40881)
Australia (6739)
California (5627)
Canada (1890)
China (493)
Colorado (259)
Connecticut (272)
Delaware (131)
Europe (88504)
Florida (834)
Georgia (204)
Idaho (61)
Illinois (540)
India (24)
Indiana (298)
Iowa (9)
Japan (143)
Kansas (103)
Kentucky (24)
Louisiana (9)
Maine (61)
Maryland (873)
Massachusetts (4287)
Michigan (215)
Minnesota (385)
Mississippi (2)
Missouri (79)
Montana (27)
Nebraska (25)
Nevada (58)
New Hampshire (67)
New Jersey (1621)
New Mexico (29)
New York (1623)
North Carolina (988)
North Dakota (7)
Northern California (2464)
Ohio (194)
Oklahoma (14)
Oregon (34)
Pennsylvania (1271)
Puerto Rico (9)
Rhode Island (29)
South America (1183)
South Carolina (19)
South Dakota (1)
Southern California (2137)
Tennessee (96)
Texas (846)
Utah (168)
Virginia (135)
Washington D.C. (61)
Washington State (533)
West Virginia (3)
Wisconsin (50)
734,010 Results for "aerin medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aerin Medical Announces Long-Term Study Demonstrating Sustained Relief for Nasal Airway Obstruction Symptoms
April 2, 2025
·
4 min read
Biotech Bay
New Two-Year Results Show Sustained Improvement in Chronic Rhinitis Symptoms Following a Single Procedure with Aerin Medical’s RhinAer®
Aerin Medical Inc. today announced the publication of positive 24-month results from RHINTRAC, a randomized, sham-controlled clinical trial, in the International Forum of Allergy & Rhinology (IFAR).
February 29, 2024
·
5 min read
Biotech Bay
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer®
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer .
February 8, 2024
·
5 min read
Business
Derrick Sung Joins Aerin Medical as Chief Financial Officer
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that Derrick Sung has been appointed chief financial officer of the company.
November 20, 2023
·
3 min read
Biotech Bay
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer®
Aerin Medical Announces Sustained Clinical and Quality-of-Life Improvements Two Years After Chronic Rhinitis Treatment with RhinAer ®.
December 5, 2023
·
5 min read
Biotech Bay
Aerin Medical Announces Advances for Chronic Rhinitis Treatment with New CPT® Code and Final CMS-Established Payment Rates
Aerin Medical Inc. announced that the Centers for Medicare and Medicaid Services assigned payment for a new Category I Current Procedural Terminology code for endoscopic destruction of the posterior nasal nerve using radiofrequency ablation.
November 3, 2023
·
4 min read
Biotech Bay
Aerin Medical Announces New Positive Two-Year Results from VivAer® AERWAY Study
Aerin Medical Inc. today announced the publication of positive two-year follow-up data from the AERWAY trial for patients with severe or extreme nasal airway obstruction (NAO) due to nasal valve collapse (NVC).
July 13, 2023
·
6 min read
Biotech Bay
Aerin Medical Supports AAO-HNS Position Recognizing Nasal Valve Repair as a Distinct Procedure that Improves Nasal Obstruction Symptoms
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, supports the recent American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) position statement.
April 18, 2023
·
4 min read
Biotech Bay
Aerin Medical Secures $60 Million in Equity Financing
Aerin Medical Inc. a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced it has recently closed a $60 million equity financing.
June 16, 2022
·
4 min read
Biotech Bay
Aerin Medical Announces Establishment of a New CPT® Code for Endoscopic Destruction of the Posterior Nasal Nerve Using Radiofrequency Ablation
Aerin Medical Inc. announced that the American Medical Association Current Procedural Terminology Editorial Panel accepted the application for a new Category I CPT code to report endoscopic destruction of the posterior nasal nerve using radiofrequency ablation.
October 18, 2022
·
3 min read
1 of 73,401
Next
